XML 55 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Convertible Preferred Stock and Stockholders Equity (Deficit) - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 27, 2021
Apr. 24, 2017
Feb. 28, 2021
Dec. 31, 2021
Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Stockholders' equity note, stock split On January 27, 2021, the Company’s Board of Directors approved a 1.8249-for-1 stock split of the Company’s outstanding common shares. On January 29, 2021, the Company amended its Amended and Restated Certificate of Incorporation to affect the stock split.        
Stockholders' equity note, stock split, conversion ratio 1.8249-for-1 stock        
Total stock-based compensation expense       $ 4,118,000 $ 833,000
General and Administrative Expense          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Total stock-based compensation expense       $ 1,573,000 233,000
Restricted Stock [Member] | Xontogeny LLC [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Shares available for future grants   3,090,924      
Common Stock [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Convertible preferred stock issued     20,549,478 20,549,478  
Common Stock [Member] | General and Administrative Expense          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Total stock-based compensation expense         $ 39,000